The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
Open accessAbstract
Chronic inflammation is a well-known risk factor for cancer. Proinflammatory mediators such as prostaglandin E2 (PGE2) promote colorectal tumor growth by stimulating angiogenesis, cell invasion, and cell growth, and inhibiting apoptosis. Molecules that regulate tumor-associated angiogenesis provide promising therapeutic targets for treatment of colorectal cancer (CRC) as indicated by the recent development of the novel anti-angiogenic agent bevacizumab (Avastin). However, use of this drug only prolongs survival by several months, highlighting the importance of finding more effective treatment regimens. We report here that PGE2 induces expression of CXCL1 (growth-regulated oncogene α), a pro-angiogenic chemokine, in human CRC cells. More importantly, CXCL1 released from carcinoma cells induces microvascular endothelial cell migration and tube formation in vitro. Furthermore, PGE2 promotes tumor growth in vivo by induction of CXCL1 expression, which results in increased tumor microvessel formation. These results have potential clinical significance because we found that CXCL1 expression correlates with PGE2 levels in human CRCs. Collectively, our findings show for the first time that CXCL1 is regulated by PGE2 and indicate that CXCL1 inhibitors should be evaluated further as potential anti-angiogenic agents for treatment of CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Self-citationCyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Self-citationOshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Self-citationColony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Self-citationColorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Self-citationMultiple control of interleukin-8 gene expression
Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H., & Kracht, M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.847 · Cited by 1,058
Angiogenesis and Tumor Metastasis
Zetter, B. R. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.407 · Cited by 1,015
Molecular cloning of gene sequences regulated by platelet-derived growth factor
Cochran, B. H., Reffel, A. C., & Stiles, C. D. (1983) · Cell · doi:10.1016/0092-8674(83)90037-5 · Cited by 945
Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 827
Self-citationPrognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Ristimaki, A. P., Sivula, A., Lundin, J. E., Lundin, M., Salminen, T. M., Haglund, C. H., Joensuu, H., & Isola, J. J. (2002) · PubMed · Cited by 780
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Host cyclooxygenase-2 modulates carcinoma growth
Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., & DuBois, R. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9621 · Cited by 673
Self-citationProstaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Self-citationAltered eicosanoid levels in human colon cancer.
Rigas, B., Goldman, I. S., & Levine, L. (1993) · PubMed · Cited by 569
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., & Langenbach, R. J. (2000) · PubMed · Cited by 496
Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., Otterson, M. F., Ota, D. M., Lügering, N., Domschke, W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208231200 · Cited by 476
Buchanan, F. G., Wang, D., Bargiacchi, F., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302474200 · Cited by 463
Self-citationThe Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer
Sheehan, K. M. (1999) · JAMA · doi:10.1001/jama.282.13.1254 · Cited by 461
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
Khuri, F. R., Wu, H., Lee, J. J., Kemp, B. L., Lotan, R., Lippman, S. M., Feng, L., Hong, W. K., & Xu, X. C. (2001) · PubMed · Cited by 406
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., & Strieter, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118734 · Cited by 403
Self-citationDuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., & Bishop, P. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116998 · Cited by 373
Self-citationRegulation of the Macrophage Content of Neoplasms by Chemoattractants
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., & Mantovani, A. (1983) · Science · doi:10.1126/science.6828888 · Cited by 352
Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., Das, S. K., Dey, S. K., & DuBois, R. N. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.011 · Cited by 340
Self-citationProstaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor
Takayama, K., Garcı́a-Cardeña, G., Sukhova, G. K., Comander, J., Gimbrone, M. A., & Libby, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204810200 · Cited by 337
COX-2: A Target for Colon Cancer Prevention
Marnett, L. J., & DuBois, R. N. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082301.164620 · Cited by 313
Self-citationTekamp-Olson, P., Gallegos, C., Bauer, D., McClain, J., Sherry, B., Fabre, M., van Deventer, S., & Cerami, A. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.911 · Cited by 289
Dormond, O., Foletti, A., Paroz, C., & Rüegg, C. (2001) · Nature Medicine · doi:10.1038/nm0901-1041 · Cited by 281
Anisowicz, A., Bardwell, L., & Sager, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7188 · Cited by 276
Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
Pugh, S., & Thomas, G. A. (1994) · Gut · doi:10.1136/gut.35.5.675 · Cited by 266
Buskens, C. J., van Rees, B. P., Sivula, A., Reitsma, J. B., Haglund, C., Bosma, P. J., Offerhaus, G. J. A., van Lanschot, J. J. B., & Ristimäki, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33580 · Cited by 230
Luan, J., Shattuck-Brandt, R., Haghnegahdar, H., Owen, J. D., Strieter, R., Burdick, M., Nirodi, C., Beauchamp, D., Johnson, K. N., & Richmond, A. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.588 · Cited by 205
Self-citationHILLYER, P., MORDELET, E., FLYNN, G., & MALE, D. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2003.02323.x · Cited by 174
Signaling angiogenesis and lymphangiogenesis
Korpelainen, E. I., & Alitalo, K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80137-3 · Cited by 174
Anisowicz, A., Messineo, M., Lee, S. W., & Sager, R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.520 · Cited by 166
Pǒld, M., Zhu, L. X., Sharma, S. P., Burdick, M. D., Lin, Y., Lee, P. P. N., Põld, A., Luo, J., Krysan, K., Dohadwala, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3262 · Cited by 160
Self-citationThe role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
Arenberg, D. A., Polverini, P. J., Kunkel, S. L., Shanafelt, A., Hesselgesser, J., Horuk, R., & Strieter, R. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.554 · Cited by 158
Self-citationDormond, O., Bezzi, M., Mariotti, A., & Rüegg, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209213200 · Cited by 152
Gaffney, D. K., Holden, J. A., Davis, M., Zempolich, K. A., Murphy, K. J., & Dodson, M. W. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01583-2 · Cited by 152
Adult Tissue Angiogenesis: Evidence for Negative Regulation by Estrogen in the Uterus
Ma, W., Tan, J., Matsumoto, H., Robert, B., Abrahamson, D. R., Das, S. K., & Dey, S. K. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.11.0734 · Cited by 133
Self-citationPurification of melanoma growth stimulatory activity
Richmond, A., & Thomas, H. G. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041290316 · Cited by 128
Self-citationProstaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells
Jing, H., Vassiliou, E. K., & Ganea, D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303116 · Cited by 114
Effects of MGSA/GRO alpha on melanocyte transformation.
Balentien, E., Mufson, B. E., Shattuck, R. L., Derynck, R., & Richmond, A. J. (1991) · PubMed · Cited by 102
Self-citationCharacterization of autostimulatory and transforming growth factors from human melanoma cells.
Richmond, A. J., Lawson, D. H., Nixon, D. W., & Chawla, R. K. (1985) · PubMed · Cited by 101
Self-citationMahmoud, N., Dannenberg, A. J., Bilinski, R. T., Mestre, J. R., Chadburn, A., Churchill, M., Martucci, C., & Bertagnolli, M. M. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.299 · Cited by 92
Nirodi, C. S., Nagdas, S. K., Gygi, S. P., Olson, G. E., Aebersold, R. H., & Richmond, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009897200 · Cited by 90
Self-citationInterleukin-8 and Growth-Regulated Oncogene Alpha Mediate Angiogenesis in Kaposi's Sarcoma
Lane, B. R., Liu, J., Bock, P. J., Schols, D., Coffey, M., Strieter, R. M., Polverini, P. J., & Markovitz, D. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11570-11583.2002 · Cited by 90
Self-citationIntestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
Kettunen, H., Kettunen, A., & Rautonen, N. (2003) · PubMed · Cited by 76
Hammond, M.-E. W., Shyamala, V., Siani, M. A., Gallegos, C., Feucht, P. H., Abbott, J., Lapointe, G., Moghadam, M. F., Khoja, H., Zakel, J. M., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8228 · Cited by 64
Giardiello, F. M., Casero, R. A., Hamilton, S. R., Hylind, L. M., Trimbath, J. D., Geiman, D. E., Judge, K. R., Hubbard, W. C., Offerhaus, G. J. A., & Yang, V. W. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.013 · Cited by 53
PAK1 Kinase Is Required for CXCL1-Induced Chemotaxis
Wang, D., Sai, J., Carter, G., Sachpatzidis, A., Lolis, E., & Richmond, A. J. (2002) · Biochemistry · doi:10.1021/bi025902m · Cited by 35
Self-citationHuman endometriotic xenografts in immunodeficient RAG-2/γ(c)KO mice
Greenberg, L. H., & Slayden, O. D. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.02.047 · Cited by 35
Franson, P. J., & Lapka, D. V. (2005) · Clinical journal of oncology nursing · doi:10.1188/05.cjon.55-60 · Cited by 12
Cited by
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Self-citationStromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Reprogramming of fatty acid metabolism in cancer
Koundouros, N., & Poulogiannis, G. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0650-z · Cited by 1,614
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
“In addition, PGE2 can induce the expression of the proangiogenic chemokine CXCL-1 in vivo [104].”
BackgroundThe role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Self-citation
Metadata
- Authors
- Wang, D., Wang, H., Brown, J., Daikoku, T., Ning, W., Shi, Q., Richmond, A., Strieter, R., Dey, S. K., & DuBois, R. N.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-03-27
- Volume
- 203
- Issue
- 4
- Pages
- 941-951
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2154504271
- Cited by
- 338
- References
- 64
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.